The medication lecanemab was approved by the U.S. FDA to treat Alzheimer’s disease in 2023. Like all medications, lecanemab comes with the potential for side effects, including amyloid-related imaging ...
NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (ABOS) (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic ...
The battle against Alzheimer’s disease continues to evolve as research uncovers more complex relationships between lifestyle factors and brain health. While exercise has long dominated conversations ...
Every family’s situation is different, and we want to help seniors enjoy the comfort of home while feeling supported.” — Rob Fraser, Owner of Care to Stay Home ...
Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference By Eisai Inc. Nov ...
Researchers from Case Western Reserve University School of Medicine have received two grant awards, in partnership with investigators from other institutions, from the National Institutes of Health to ...
Hosted on MSN
Does Alzheimer’s Affect Sleep? What You Should Know
Sleep plays a critical role in memory, cognitive performance, and overall health. But for individuals with Alzheimer’s disease—a progressive neurodegenerative condition that impacts memory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback